These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 27161640)

  • 1. Potential Use of Fosfomycin-Tromethamine for Treatment of Recurrent Campylobacter Species Enteritis.
    Aguilar-Company J; Los-Arcos I; Pigrau C; Rodríguez-Pardo D; Larrosa MN; Rodríguez-Garrido V; Sihuay-Diburga D; Almirante B
    Antimicrob Agents Chemother; 2016 Jul; 60(7):4398-400. PubMed ID: 27161640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical trial of fosfomycin for Campylobacter enteritis].
    Nogawa T; Takeuchi Y; Watanabe J; Kimura K; Tomii I; Abe T; Watanabe Y; Nakasone K; Fujimori I; Kobayashi Y
    Jpn J Antibiot; 1984 Sep; 37(9):1620-4. PubMed ID: 6512981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of fosfomycin in Campylobacter jejuni enteritis].
    Fuchigami T; Ootaki A; Fujita Y; Yoza A; Ryo S; Nishiyama N
    Jpn J Antibiot; 1983 Oct; 36(10):2849-55. PubMed ID: 6674520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fosfomycin tromethamine as second agent for the treatment of acute, uncomplicated urinary tract infections in adult female patients in The Netherlands?
    Knottnerus BJ; Nys S; Ter Riet G; Donker G; Geerlings SE; Stobberingh E
    J Antimicrob Chemother; 2008 Aug; 62(2):356-9. PubMed ID: 18424789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Fosfomycin-Tromethamine Oral Therapy for Difficult-To-Treat Chronic Bacterial Prostatitis.
    Los-Arcos I; Pigrau C; Rodríguez-Pardo D; Fernández-Hidalgo N; Andreu A; Larrosa N; Almirante B
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1854-8. PubMed ID: 26666924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fosfomycin tromethamine in uncomplicated urinary tract infections: a clinical study.
    Bonfiglio G; Mattina R; Lanzafame A; Cammarata E; Tempera G;
    Chemotherapy; 2005 May; 51(2-3):162-6. PubMed ID: 15886477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of effectiveness of rokitamycin dry syrup in acute enteritis in pediatrics. A comparative study on rokitamycin and fosfomycin dry syrups].
    Motohiro T; Aramaki M; Oda K; Kawakami A; Tanaka K; Koga T; Sakata Y; Yamashita F; Suzuki K; Ishii M
    Jpn J Antibiot; 1990 Feb; 43(2):257-84. PubMed ID: 2194055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antibacterial activity of fosfomycin against the causative bacteria isolated from bacterial enteritis].
    Fukuyama M; Furuhata K; Oonaka K; Hara T; Sunakawa K
    Jpn J Antibiot; 2000 Jul; 53(7):522-31. PubMed ID: 11019386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of the trometamol salt of fosfomycin in an in vitro model of the treatment of bacterial cystitis.
    Greenwood D
    Infection; 1986; 14(4):186-9. PubMed ID: 3531023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-dose treatment of acute cystitis with fosfomycin tromethamine.
    Stein GE
    Ann Pharmacother; 1998 Feb; 32(2):215-9. PubMed ID: 9496408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fosfomycin tromethamine in uncomplicated urinary tract infections: an epidemiological survey.
    Tempera G; Mirabile M; Mangiafico A; Caccamo M; Bonfiglio G
    J Chemother; 2004 Apr; 16(2):216-7. PubMed ID: 15216960
    [No Abstract]   [Full Text] [Related]  

  • 12. Fosfomycin tromethamine: single-dose treatment of acute cystitis.
    Stein GE
    Int J Fertil Womens Med; 1999; 44(2):104-9. PubMed ID: 10338268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Short communication: comparison of susceptibilities of Escherichia coli urinary tract isolates against fosfomycin tromethamine and different antibiotics].
    Aykut Arca E; Karabiber N
    Mikrobiyol Bul; 2007 Jan; 41(1):115-9. PubMed ID: 17427560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Campylobacter enteritis in the Arabian Gulf.
    Senok AC; Botta GA
    J Infect Dev Ctries; 2009 Mar; 3(2):74-82. PubMed ID: 19755734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fosfomycin in the treatment of some infectious diseases].
    Aceti A; Vullo V; Ferone U; Delia S
    Clin Ter; 1979 Jan; 88(1):61-6. PubMed ID: 436378
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro activity of fosfomycin tromethamine against extended spectrum beta-lactamase producing urinary tract bacteria.
    Khan IU; Mirza IA; Ikram A; Ali S; Hussain A; Ghafoor T
    J Coll Physicians Surg Pak; 2014 Dec; 24(12):914-7. PubMed ID: 25523727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics and antimicrobial choice of pediatric bacterial enteritis in the Kanto region of Japan: A multicenter retrospective observational study.
    Kasai Y; Komatsu M; Toyama Y; Nakano S; Hisata K; Niizuma T; Obinata K; Shimizu T
    J Infect Chemother; 2022 Jun; 28(6):723-728. PubMed ID: 35232682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fosfomycin in the treatment of bacterial infections: summary of clinical trials in Japan.
    Fujii R
    Chemotherapy; 1977; 23 Suppl 1():234-46. PubMed ID: 832522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Campylobacter enteritis in adult patients with acute diarrhea from 2005 to 2009 in Beijing, China.
    Chen J; Sun XT; Zeng Z; Yu YY
    Chin Med J (Engl); 2011 May; 124(10):1508-12. PubMed ID: 21740807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent Campylobacter Enteritis in Patients with Hypogammaglobulinemia: Review of the Literature.
    Najjar I; Paluca F; Loukidis K; Tarr PE
    J Clin Med; 2020 Feb; 9(2):. PubMed ID: 32085573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.